Abstrait
Si les métastases cutanées des cancers profonds sont parfois révélatrices du cancer, elles surviennent cependant le plus souvent au cours de son évolution. Elles sont le témoin d’un stade avancé de la maladie. Tous les cancers peuvent être àl’origine de métastases cutanées. Le diagnostic est important car, si elles sont révélatrices, elles peuvent permettre de retrouver un cancer primitif, parfois être accessible àune thérapeutique efficace et, si elles surviennent dans un contexte de cancer connu, elles sont le témoin d’une évolutivité de la maladie qui peut justifier une modification de stratégie thérapeutique. Les localisations cutanées secondaires du mélanome et les localisations des affections malignes des tissus hématopoïétiques ne seront pas abordées ici.
Preview
Unable to display preview. Download preview PDF.
Références
Schwartz RA. Cutaneous metastatic disease. J Am Acad Dermatol 1995; 33:161–182.
Brownstein MH, Helwig EB. Metastatic tumors of the skin. Cancer 1972; 39:1298–1307.
Miyashita M, Inadomi T, Suzuki H. Possible role of mucin in hair loss in alopecia neoplastica. Eur J Dermatol 1994; 4:434–436.
Bianchi L, Orlandi A, Carboni I et al. Zosteriform metastasis of occult bronchogenic carcinoma. Acta Derm Venereal 2000; 80:391–392.
French NH, Williams TS, Callen JP. Rhinophyma-like swelling of the nose due to squamous cell carcinoma of the lung metastatic to nasal tip: a case report. Eur J Dermatol 1995; 5: 131–134.
Lin JH, Lee JYY, Chao SC et al. Telangiectatic metastatic breast carcinoma preceded by en cuirasse metastatic breast carcinoma. Br J Dermatol 2004; 150:523–524.
Dereure O, Guilhou JJ, Guiiiot B. An unusual clinical pattern of cutaneous metastasis: target-like lesions. Br J Dermatol 2003; 148: 361.
Dereure O, Blatiere V, Guillot B. Multiple haemorraghic-like cutaneous metastasis of malignant melanoma. Eur J Dermatol 2005; 15: 409–410.
Powell FC, Cooper AJ, Massa MA et al. Sister Mary Joseph’s nodule: a clinical and histologic study. J Am Acad Dermatol 1984; 10:610–615.
Baran R, Tosti A. Metastatic carcinoma to the terminal phalanx of the big toe: report of two cases and rewiew of the literature. J Am Acad dermatol 1994; 31:259–263.
Lookingbill DP, Spangler N, Sexton FM. Skin involvement as the presenting sign of internal carcinoma. J Am Acad Dermatol 1990; 22: 19–26.
Lookingbill DP, Spangler N, Helm KF. Cutaneous métastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol 1993; 29:228–236.
Wesche WA, Khare VK, Chesney TM et al. Non-hematopoietic cutaneous métastases in children and adolescents: thirty years experience at St Jude Children’s Research Hospital. J Cutan Pathol 2000; 27:485–492.
Mueller TJ, Wu H, Greenberg RE et al. Cutaneous metastasis from genitourinary malignancies. Urology 2004; 63:1021–1026.
Cariou B, Charbonnel B, Heymann MF et al. Métastase cutanée d’un carcinome vésiculaire de la thyroïde. Presse Med 2000; 29:1557–1558.
Rao UNM, Hanan SH, Lotze MT et.al. Distant skin and soft tissue métastases from sarcomas. J Surg Oncol 1998; 69:94–98.
Figueroa P, Lupton JR, Remington T, et al. Cutaneous metastasis from an intracranial glioblastoma multiforme. J Am Acad Dermatol 2002; 46:297–300.
Jain N, Mirakhur M, Flynn P et al. Cutaneous metastatis from gliobiastoma. Br J Neurosurg 2005; 19:65–68.
Maiorana A, Gisuti F, Cesinaro AM et al. Cutaneous metastasis as the first manifestation of pleural malignant mesothelioma. J Am Acad Dermatol 2006; 54:363–365.
Berkowitz Rk, Longley J, Buchess MR et al. Malignant mesothelioma: diagnosis by skin biopsy. J Am Acad Dermatol 1989; 21:1068.
Fornaserio A, Daniele O, Sperandino P et al. Chemotherapy of invasive or metastatic thymoma: report of 11 cases. Cancer Treat Rep 1984; 68:1205–1210.
Ruiz HA, Goldberg LH, Humphreys TR et al. Cutaneous metastasis of chordoma. Dermatol Surg 2000; 26:259–262.
Bodemer C, Dubois M, Droz D et al. Métastases cutanées congénitales d’un neuroblastome. Ann Dermatol Venereal 1990; 117:798–800.
Castello MA, Clerico A, Operamolla P et al. Neonatal neuroblastoma: stage of disease influences survival. Anticancer Res 1983; 3:311–312.
Schwartz RA. Histopathologic aspects of cutaneous metastatic disease. J Am Acad Dermatol 1995; 33:649–657.
Leroy X, Copin Mc, Boman F et al. Les cytokératines 7 et 20: aide au typage des tumeurs. Ann Pathol 1998; 18:103–109.
Azoulay S, Adem C, Pelletier FL et al. Skin metastases from unknown origin: role of immunohistochemistry in the evaluation of cutaneous métastases of carcinoma of unknown origin. J Cutan Pathol 2005; 32:561–566.
Sariya D, Ruth K, Adams-McDonnell R et al. Clinicopathologic correlation of cutaneous métastases: experience from a cancer center. Arch Dermatol 2007; 143:613–620.
Kanitakis J, Faure M, Claudy A. Apport de l’immunohistochimie au diagnostic des tumeurs cutanées. Ann Dermatol Venereal 1998; 125:354–369
Schoenlaub P, Sarraux A, Grosshans E et al. Survie après métastases cutanées: étude de 200 cas. Ann Dermatol Venereal 2001; 128:1310–1315.
Peng, Q, Warloe T, Berg C et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical response and future challenges. Cancer 1997; 79:2282–2308.
Wandt H, Gallmeier WM. A new treatment option in patients with cutaneous lesions from breast cancer: topical application of miltefosine. Onkologie 1994; 17:16–19.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Guillot, B. (2009). Métastasts cutanées. In: Manifestations dermatologiques des maladies du système hématopoïétique et oncologie dermatologique. Springer, Paris. https://doi.org/10.1007/978-2-287-72092-5_22
Download citation
DOI: https://doi.org/10.1007/978-2-287-72092-5_22
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-72091-8
Online ISBN: 978-2-287-72092-5